Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302645 | 0.94 | MAPT (0.50) | MAPTHSD17B10EPHX1TSHREPHX2 | |
| SCHEMBL301433 | 0.89 | TSHR (0.51) | HSD17B10TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL14889325 | 0.83 | TSHR (0.47) | HSD17B10TSHRCA14SMN1; SMN2ALDH1A1 | |
| SCHEMBL4873828 | 0.82 | MAPT (0.41) | MAPTHSD17B10EPHX1TSHREPHX2 | |
| SCHEMBL4881440 | 0.81 | TSHR (0.50) | HSD17B10TSHREPHX2RECQLCA14 | |
| SCHEMBL4881902 | 0.80 | ALDH1A1 (0.54) | HSD17B10TSHRSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL18287170 | 0.80 | EPHX1 (0.59) | EPHX1MMP8SMN1; SMN2 | |
| SCHEMBL18287168 | 0.80 | EPHX1 (0.59) | EPHX1MMP8SMN1; SMN2 | |
| SCHEMBL18287161 | 0.80 | EPHX1 (0.59) | EPHX1MMP8SMN1; SMN2 | |
| SCHEMBL12449353 | 0.79 | KDM4C (0.42) | EPHX1MMP9SMN1; SMN2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079321-B1 | COOLING CONFECTIONERIES AND BEVERAGES | KRAFT FOODS GLOBAL BRANDS LLC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20110159141-A1 | COOLING CONFECTIONERIES AND BEVERAGES | INTERCONTINENTAL GREAT BRANDS LLC | 2011-06-30 | — | — | US | claimed |
| EP-2079321-A1 | COOLING CONFECTIONERIES AND BEVERAGES | Cadbury Adams USA LLC (US) | 2009-07-22 | — | — | EP | claimed |
| WO-2008039522-A1 | COOLING CONFECTIONERIES AND BEVERAGES | CADBURY ADAMS USA LLC (US) | 2008-04-03 | — | — | WO | claimed |
| EP-2375912-B1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2017-08-23 | — | — | EP | disclosed |
| US-20130330396-A1 | METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2013-12-12 | — | — | US | disclosed |
| US-20130216648-A1 | CHEWING GUM COMPOSITIONS PROVIDING FLAVOR RELEASE PROFILES | KRAFT FOODS GLOBAL BRANDS LLC (US) | 2013-08-22 | — | — | US | disclosed |
| EP-2079321-B1 | COOLING CONFECTIONERIES AND BEVERAGES | KRAFT FOODS GLOBAL BRANDS LLC (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20120114735-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | INTERCONTINENTAL GREAT BRANDS LLC | 2012-05-10 | — | — | US | disclosed |
| US-20120040050-A1 | CHEWING GUM COMPOSITIONS PROVIDING FLAVOR RELEASE PROFILES | INTERCONTINENTAL GREAT BRANDS LLC | 2012-02-16 | — | — | US | disclosed |
| EP-2375912-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | Kraft Foods Global Brands LLC (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20110159141-A1 | COOLING CONFECTIONERIES AND BEVERAGES | INTERCONTINENTAL GREAT BRANDS LLC | 2011-06-30 | — | — | US | disclosed |
| WO-2010083133-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | CADBURY ADAMS USA LLC (US) | 2010-07-22 | — | — | WO | disclosed |
| EP-2079321-A1 | COOLING CONFECTIONERIES AND BEVERAGES | Cadbury Adams USA LLC (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008039522-A1 | COOLING CONFECTIONERIES AND BEVERAGES | CADBURY ADAMS USA LLC (US) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130330396-A1 | METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | TAS2R43, TAS2R14, TAS2R31 | MAPT 4157/4885HSD17B10 1629/4885EPHX1 3544/4885 |
| US-20120114735-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THROAT DISCOMFORT | TAS2R43, TAS2R14, TAS2R8 | MAPT 3713/4885HSD17B10 1752/4885EPHX1 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.